A man wearing a face mask takes part in the double blind randomized placebo-controlled study of Russia's Sputnik V vaccine, at the City Polyclinic №28, in Minsk, Belarus. One hundred people will have the opportunity to get inoculated with the Sputnik V vaccine, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.
